Atria Wealth Solutions, Inc. Horizon Therapeutics Public LTD CO Transaction History

Atria Wealth Solutions, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 14, 2023	BUY	$107.32 - $113.5 $643,705 - $680,773	5,998 New	5,998 $654,000
Q4 2022 Aug 30, 2023	BUY	$62.39 - $113.8 $374,215 - $682,572	5,998 New	5,998 $682,000
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $105,751 - $192,891	1,695 Added 24.01%	8,754 $996,000
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $178,998 - $257,227	-3,038 Reduced 30.09%	7,059 $437,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $210,092 - $307,888	2,646 Added 35.51%	10,097 $806,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $643,915 - $818,194	7,451 New	7,451 $784,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.